# Verisign Inc: financial statements, quarterly VRSN · Nasdaq · CIK 1014473 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/vrsn.md) · [Financials](/companies/vrsn/financials.md) · [Filings](/companies/vrsn/filings.md) · [Insiders](/companies/vrsn/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/vrsn/financials.md?period=annual). ## Income statement | Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [380 d](/filings/0001014473-26-000006.md) | [384](/filings/0001014473-25-000021.md) | [387](/filings/0001014473-25-000036.md) | [391](/filings/0001014473-25-000046.md) | [395 d](/filings/0001014473-26-000006.md) | [402](/filings/0001014473-26-000020.md) | [410](/filings/0001014473-26-000028.md) | [419](/filings/0001014473-26-000039.md) | [425 d](/filings/0001014473-26-000006.md) | [429](/filings/0001014473-26-000020.md) | [435](/filings/0001014473-26-000028.md) | [443](/filings/0001014473-26-000039.md) | | Cost of revenue | $m | [48.5 d](/filings/0001014473-26-000006.md) | [49.1](/filings/0001014473-25-000021.md) | [47.1](/filings/0001014473-25-000036.md) | [46.8](/filings/0001014473-25-000046.md) | [48.4 d](/filings/0001014473-26-000006.md) | [49.4](/filings/0001014473-26-000020.md) | [49.1](/filings/0001014473-26-000028.md) | [48.8](/filings/0001014473-26-000039.md) | [49.0 d](/filings/0001014473-26-000006.md) | [49.2](/filings/0001014473-26-000020.md) | [50.0](/filings/0001014473-26-000028.md) | [49.8](/filings/0001014473-26-000039.md) | | Research and development | $m | [22.9 d](/filings/0001014473-26-000006.md) | [24.8](/filings/0001014473-25-000021.md) | [23.8](/filings/0001014473-25-000036.md) | [23.2](/filings/0001014473-25-000046.md) | [24.9 d](/filings/0001014473-26-000006.md) | [26.0](/filings/0001014473-26-000020.md) | [25.7](/filings/0001014473-26-000028.md) | [25.4](/filings/0001014473-26-000039.md) | [26.5 d](/filings/0001014473-26-000006.md) | [27.5](/filings/0001014473-26-000020.md) | [27.5](/filings/0001014473-26-000028.md) | [26.5](/filings/0001014473-26-000039.md) | | Selling, general and administrative | $m | [52.7 d](/filings/0001014473-26-000006.md) | [51.5](/filings/0001014473-25-000021.md) | [50.0](/filings/0001014473-25-000036.md) | [51.3](/filings/0001014473-25-000046.md) | [58.3 d](/filings/0001014473-26-000006.md) | [55.7](/filings/0001014473-26-000020.md) | [54.4](/filings/0001014473-26-000028.md) | [60.6](/filings/0001014473-26-000039.md) | [65.0 d](/filings/0001014473-26-000006.md) | [58.6](/filings/0001014473-26-000020.md) | [60.8](/filings/0001014473-26-000028.md) | [70.2](/filings/0001014473-26-000039.md) | | Operating income | $m | [256 d](/filings/0001014473-26-000006.md) | [259](/filings/0001014473-25-000021.md) | [266](/filings/0001014473-25-000036.md) | [269](/filings/0001014473-25-000046.md) | [264 d](/filings/0001014473-26-000006.md) | [271](/filings/0001014473-26-000020.md) | [281](/filings/0001014473-26-000028.md) | [284](/filings/0001014473-26-000039.md) | [285 d](/filings/0001014473-26-000006.md) | [294](/filings/0001014473-26-000020.md) | [296](/filings/0001014473-26-000028.md) | [297](/filings/0001014473-26-000039.md) | | Interest expense | $m | [18.8 d](/filings/0001014473-26-000006.md) | [18.8](/filings/0001014473-25-000021.md) | [18.8](/filings/0001014473-25-000036.md) | [18.9](/filings/0001014473-25-000046.md) | [18.8 d](/filings/0001014473-26-000006.md) | [20.3](/filings/0001014473-26-000020.md) | [18.9](/filings/0001014473-26-000028.md) | [18.9](/filings/0001014473-26-000039.md) | [18.9 d](/filings/0001014473-26-000006.md) | [18.9](/filings/0001014473-26-000020.md) | [19.2](/filings/0001014473-26-000028.md) | [21.2](/filings/0001014473-26-000039.md) | | Income tax | $m | [(13.1) d](/filings/0001014473-26-000006.md) | [59.9](/filings/0001014473-25-000021.md) | [60.1](/filings/0001014473-25-000036.md) | [59.6](/filings/0001014473-25-000046.md) | [56.6 d](/filings/0001014473-26-000006.md) | [59.1](/filings/0001014473-26-000020.md) | [59.9](/filings/0001014473-26-000028.md) | [58.9](/filings/0001014473-26-000039.md) | [64.9 d](/filings/0001014473-26-000006.md) | [64.9](/filings/0001014473-26-000020.md) | [65.1](/filings/0001014473-26-000028.md) | [67.0](/filings/0001014473-26-000039.md) | | Net income | $m | [265 d](/filings/0001014473-26-000006.md) | [194](/filings/0001014473-25-000021.md) | [199](/filings/0001014473-25-000036.md) | [201](/filings/0001014473-25-000046.md) | [192 d](/filings/0001014473-26-000006.md) | [199](/filings/0001014473-26-000020.md) | [207](/filings/0001014473-26-000028.md) | [213](/filings/0001014473-26-000039.md) | [206 d](/filings/0001014473-26-000006.md) | [215](/filings/0001014473-26-000020.md) | [217](/filings/0001014473-26-000028.md) | [213](/filings/0001014473-26-000039.md) | | Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Basic EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue: us-gaap:Revenues - Cost of revenue: us-gaap:CostOfRevenue - Research and development: us-gaap:ResearchAndDevelopmentExpense - Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpense - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:ProfitLoss, us-gaap:NetIncomeLoss - Diluted EPS: not reported - Basic EPS: not reported ## Balance sheet | Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [240](/filings/0001014473-25-000006.md) | [732](/filings/0001014473-24-000023.md) | [252](/filings/0001014473-24-000033.md) | [267](/filings/0001014473-24-000040.md) | [207](/filings/0001014473-26-000006.md) | [575](/filings/0001014473-25-000021.md) | [314](/filings/0001014473-25-000036.md) | [235](/filings/0001014473-25-000046.md) | [308](/filings/0001014473-26-000039.md) | [477](/filings/0001014473-26-000020.md) | [841](/filings/0001014473-26-000028.md) | [207](/filings/0001014473-26-000039.md) | | Current assets | $m | [988](/filings/0001014473-25-000006.md) | [988](/filings/0001014473-24-000023.md) | [761](/filings/0001014473-24-000033.md) | [717](/filings/0001014473-24-000040.md) | [664](/filings/0001014473-26-000006.md) | [714](/filings/0001014473-25-000021.md) | [682](/filings/0001014473-25-000036.md) | [688](/filings/0001014473-25-000046.md) | [653](/filings/0001014473-26-000039.md) | [626](/filings/0001014473-26-000020.md) | [1,122](/filings/0001014473-26-000028.md) | [574](/filings/0001014473-26-000039.md) | | Total assets | $m | [1,749](/filings/0001014473-25-000006.md) | [1,728](/filings/0001014473-24-000023.md) | [1,505](/filings/0001014473-24-000033.md) | [1,462](/filings/0001014473-24-000040.md) | [1,407](/filings/0001014473-26-000006.md) | [1,448](/filings/0001014473-25-000021.md) | [1,408](/filings/0001014473-25-000036.md) | [1,404](/filings/0001014473-25-000046.md) | [1,326](/filings/0001014473-26-000039.md) | [1,297](/filings/0001014473-26-000020.md) | [1,803](/filings/0001014473-26-000028.md) | [1,280](/filings/0001014473-26-000039.md) | | Current liabilities | $m | [1,189](/filings/0001014473-25-000006.md) | [1,214](/filings/0001014473-24-000023.md) | [1,191](/filings/0001014473-24-000033.md) | [1,526](/filings/0001014473-24-000040.md) | [1,531](/filings/0001014473-26-000006.md) | [1,287](/filings/0001014473-25-000021.md) | [1,260](/filings/0001014473-25-000036.md) | [1,307](/filings/0001014473-25-000046.md) | [1,333](/filings/0001014473-26-000039.md) | [1,355](/filings/0001014473-26-000020.md) | [1,899](/filings/0001014473-26-000028.md) | [1,381](/filings/0001014473-26-000039.md) | | Total liabilities | $m | [3,330](/filings/0001014473-25-000006.md) | [3,364](/filings/0001014473-24-000023.md) | [3,322](/filings/0001014473-24-000033.md) | [3,363](/filings/0001014473-24-000040.md) | [3,364](/filings/0001014473-26-000006.md) | [3,425](/filings/0001014473-25-000021.md) | [3,402](/filings/0001014473-25-000036.md) | [3,454](/filings/0001014473-25-000046.md) | [3,480](/filings/0001014473-26-000039.md) | [3,511](/filings/0001014473-26-000020.md) | [4,057](/filings/0001014473-26-000028.md) | [3,565](/filings/0001014473-26-000039.md) | | Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Shareholders' equity | $m | [(1,581)](/filings/0001014473-25-000046.md) | [(1,636)](/filings/0001014473-25-000036.md) | [(1,816)](/filings/0001014473-25-000046.md) | [(1,901)](/filings/0001014473-25-000046.md) | [(1,958)](/filings/0001014473-26-000039.md) | [(1,977)](/filings/0001014473-26-000028.md) | [(1,994)](/filings/0001014473-26-000039.md) | [(2,051)](/filings/0001014473-26-000039.md) | [(2,154)](/filings/0001014473-26-000039.md) | [(2,213)](/filings/0001014473-26-000028.md) | [(2,254)](/filings/0001014473-26-000039.md) | [(2,285)](/filings/0001014473-26-000039.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: not reported - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [204 d](/filings/0001014473-26-000006.md) | [257](/filings/0001014473-25-000021.md) | [160 d](/filings/0001014473-25-000036.md) | [253 d](/filings/0001014473-25-000046.md) | [232 d](/filings/0001014473-26-000006.md) | [291](/filings/0001014473-26-000020.md) | [203 d](/filings/0001014473-26-000028.md) | [308 d](/filings/0001014473-26-000039.md) | [290 d](/filings/0001014473-26-000006.md) | [272](/filings/0001014473-26-000020.md) | [232 d](/filings/0001014473-26-000028.md) | [268 d](/filings/0001014473-26-000039.md) | | Capital expenditure | $m | [5.0 d](/filings/0001014473-26-000006.md) | [3.8](/filings/0001014473-25-000021.md) | [9.2 d](/filings/0001014473-25-000036.md) | [5.6 d](/filings/0001014473-25-000046.md) | [9.5 d](/filings/0001014473-26-000006.md) | [5.8](/filings/0001014473-26-000020.md) | [7.8 d](/filings/0001014473-26-000028.md) | [4.7 d](/filings/0001014473-26-000039.md) | [4.5 d](/filings/0001014473-26-000006.md) | [7.2](/filings/0001014473-26-000020.md) | [18.8 d](/filings/0001014473-26-000028.md) | [7.6 d](/filings/0001014473-26-000039.md) | | Dividends paid | $m | not reported | not reported | not reported | [0.0 d](/filings/0001014473-25-000046.md) | [0.0 d](/filings/0001014473-26-000006.md) | [0.0](/filings/0001014473-26-000020.md) | [72.1](/filings/0001014473-26-000006.md) | [72.0](/filings/0001014473-26-000006.md) | [71.1](/filings/0001014473-26-000006.md) | [74.2](/filings/0001014473-26-000039.md) | [73.6](/filings/0001014473-26-000039.md) | [73.0](/filings/0001014473-26-000039.md) | | Share repurchases | $m | [226 d](/filings/0001014473-26-000006.md) | [270](/filings/0001014473-25-000021.md) | [390](/filings/0001014473-24-000033.md) | [303](/filings/0001014473-24-000040.md) | [262 d](/filings/0001014473-26-000006.md) | [242](/filings/0001014473-26-000020.md) | [167](/filings/0001014473-25-000036.md) | [219](/filings/0001014473-25-000046.md) | [254 d](/filings/0001014473-26-000006.md) | [225](/filings/0001014473-26-000020.md) | [201](/filings/0001014473-26-000028.md) | [193](/filings/0001014473-26-000039.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Dividends paid: us-gaap:PaymentsOfDividends - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [105](/filings/0001014473-24-000023.md) | [104](/filings/0001014473-24-000033.md) | [103](/filings/0001014473-24-000040.md) | [101](/filings/0001014473-25-000021.md) | [99.0](/filings/0001014473-25-000036.md) | [97.3](/filings/0001014473-25-000046.md) | [94.8](/filings/0001014473-26-000020.md) | [94.0](/filings/0001014473-26-000028.md) | [93.6](/filings/0001014473-26-000039.md) | [91.8](/filings/0001014473-26-000020.md) | [91.1](/filings/0001014473-26-000028.md) | [90.4](/filings/0001014473-26-000039.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 89,700,000 at 2026-10-16, from the cover of the [10-Q filed 2026-10-22](/filings/0001014473-26-000039.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.